@basquiera profile picture
Ana Lisa Basquiera @basquiera
Joined April 2019
  • Tweets 1,171
  • Following 346
  • Followers 515
42 Photos and videos
Ana Lisa Basquiera retweeted
Gonzalo Bentolila@GonzaloBentoli1
Jun 11
Huge congratulations, @NicoGagelmann, on the EHA Young Investigator Award! No one deserves it more. Your passion, creativity, and commitment to advancing our field make this recognition incredibly well earned.
5
5
39
2,960
Community-acquired respiratory virus infections in patients with haematological malignancies or undergoing haematopoietic cell transplantation: updated recommendations from the 10th ECIL-Guidelines- The Lancet Infectious Diseases thelancet.com/journals/lanin…

Community-acquired respiratory virus infections in patients with haematological malignancies or...

To update recommendations of the 4th European Conference on Infections in Leukaemia (ECIL-4) on community-acquired respiratory virus (CARV) infections published in 2013, we reviewed publications from...

thelancet.com
5
14
1,205
Ana Lisa Basquiera retweeted
Eric Topol
@EricTopol
May 26
Deep B cell depletion is rebooting the immune system, the basis for a potential curative approach to a long list of autoimmune diseases nature.com/articles/s41591-0…
9
86
370
39,630
Ana Lisa Basquiera retweeted
ICCBBA@ISBT128
May 27
How does the ISBT 128 Standard support cross-border traceability and patient safety across Europe? 🌍Read our latest blog to learn more. 🔗 na2.hubs.ly/H05M3rM0 #ICCBBA #ISBT128Standard #Traceability #PatientSafety
1
1
30
Ana Lisa Basquiera retweeted
Unidad Académica de Hematología.@CatedraHemato
May 20
Síndromes Mielodisplásicos de Bajo Riesgo. Abordaje diagnóstico y terapéutico @SofiaGrille @matilde_boada
3
7
353
FDA approves early warning system for sepsis hub.jhu.edu/2026/05/12/fda-a… via @HubJHU

FDA approves early warning system for sepsis

The AI system detects deadly infections faster than doctors, saving thousands of lives from a condition that claims more than 250,000 lives each year in the U.S.

hub.jhu.edu
1
41
Ana Lisa Basquiera retweeted
Felipe Peña-Muñoz@HematoRules
May 22
Today in Dubrovnik at 8th International Chronic Graft-versus-Host Disease Symposium sharing the results of our Belumosudil analysis 🇮🇹 🇪🇸 🇬🇧 #cGvHD #HSTC
2
5
622
Ana Lisa Basquiera retweeted
Blood Journals Portfolio@BloodPortfolio
May 17
HLA matching did not affect late transplantation outcomes after PT-Cy–based GVHD prophylaxis. Older donor age and female-to-male donor-recipient sex mismatch were associated with increased late NRM. Read in Blood Neoplasia: ow.ly/okwu50YV43C
8
27
2,002
Ana Lisa Basquiera retweeted
Blood Cancer Journal@BloodCancerJnl
May 7
Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T. | Blood Cancer Journal nature.com/articles/s41408-0…

Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma...

Blood Cancer Journal - Validation and refinement of the new Consensus Genomic Staging (CGS) of high-risk multiple myeloma (HRMM) in relapsed and refractory patients treated with BCMA CAR-T.

nature.com
3
6
558
Ana Lisa Basquiera retweeted
Emma M. Groarke@emmamgroarke
May 7
Super excited to share our How-I-Treat our today in @BloodPortfolio where we show how we integrate somatic mutations and other alterations 🧬 into the diagnosis and clinical care of #BMFsm patients. @fergutierrezro1 @bhavishap29 @NIH ashpublications.org/blood/ar…
4
22
74
6,272
Ana Lisa Basquiera retweeted
Dr Rudra Narayan Swain M.D , D.M
@rudra09s025
Apr 15
What should be the optimal strategy after AZA–VEN–induced remission in younger AML patients not proceeding to allo-HSCT? Our recent work explores this clinically relevant question. Read more in @BloodCancerJnl : 👉doi.org/10.1038/s41408-026-0… Grateful to @ArihantDr, @DrGPrakash, and @DrPMPGI Sir, for their invaluable support and conceptual guidance. @AML_Hub #leusm #Hematology @blood_academy @SOAsocialmedia @ims_sum
7
26
99
11,448
Ana Lisa Basquiera retweeted
Matilde Boada@matilde_boada
Apr 24
Invitados que son todo lo que está bien 💪🏻💪🏻💪🏻 Dr. Scott Howard @basquiera
3
9
659
Ana Lisa Basquiera retweeted
Unidad Académica de Hematología.@CatedraHemato
Apr 24
Discusión de casos clínicos con un gran panel 💪🏻 @avazquez4 @basquiera
1
5
257
Ana Lisa Basquiera retweeted
Unidad Académica de Hematología.@CatedraHemato
Apr 21
Finalizamos nuestro curso de Enfermería en CART con invitada de lujo @mercedesmontoro @hospitalclinic y una concurrencia excepcional presencial y virtual 👏👏 @Carlitocha Gracias a todos por acompañarnos
2
10
822
Ana Lisa Basquiera retweeted
Unidad Académica de Hematología.@CatedraHemato
Apr 23
4tas Jornadas Integradas de Hematología “Hematología al día” con un gran equipo 💪🏻 @SofiaGrille @Mariana17174661 @erivaserra @matilde_boada @SabrinaRanero @vicmatosas @ini_gervaz @leti_007 @andresaddiego
1
8
17
944
Ana Lisa Basquiera retweeted
Unidad Académica de Hematología.@CatedraHemato
Apr 24
Leucemias agudas mieloblasticas en la era de los tratamientos target y los planes libres de quimioterapia @basquiera @matilde_boada @ini_gervaz @avazquez4
3
6
393
Ana Lisa Basquiera retweeted
Unidad Académica de Hematología.@CatedraHemato
Apr 23
Mesa de lujo en Mieloma Múltiple @erivaserra @basquiera
1
1
175
Ana Lisa Basquiera retweeted
Mostafa Faisal@MostafaFaisal14
Apr 19
Efficacy of Low-Dose Olanzapine for the Prevention of Conditioning Therapy-Induced Nausea and Vomiting in Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation astctjournal.org/article/S26…

Efficacy of Low-Dose Olanzapine for the Prevention of Conditioning Therapy-Induced Nausea and...

Allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a curative therapy for hematological malignancies. Pre-transplant conditioning therapy is crucial for preventing rejection and...

astctjournal.org
1
2
6
485
Ana Lisa Basquiera retweeted
Mostafa Faisal@MostafaFaisal14
Apr 18
Are HLA-Haploidentical Relatives a Donor Choice for Patients with Severe Aplastic Anemia? A GATMO-TC Experience @ASTCT_Journal astctjournal.org/article/S26…

Are HLA-Haploidentical Relatives a Donor Choice for Patients With Severe Aplastic Anemia? A...

Aplastic anemia is an immune-mediated disorder characterized by the immunological destruction of hematopoietic precursors in the bone marrow leading to severe cytopenias [1]. The severity of AA has...

astctjournal.org
1
4
15
939
Ana Lisa Basquiera retweeted
Gonzalo Bentolila@GonzaloBentoli1
Apr 17
Thrilled to share this collaborative work from GATMO-TC exploring whether HLA-haploidentical related donors may represent a donor choice for patients with severe aplastic anemia. A true multicenter effort from Argentina. doi.org/10.1016/j.jtct.2026.…
3
13
26
2,753
Load more